Answers are grounded in this paper and cite their sources.
Systematic review shows inorganic nitrate improves endothelial function in patients, indicating cardiovascular benefits.
Context Inorganic nitrate is an exogenous source of nitric oxide, an established regulator of vascular homeostasis via the nitrate-nitrite-nitric oxide pathway. Here, we evaluate the impact of inorganic nitrate on endothelial function, a risk factor for cardiovascular disease. Objective A systematic review of the existing literature and meta-analysis was performed. Trials testing inorganic nitrate compared with a control were selected and the change in forearm endothelial function (as assessed by flow-mediated dilatation [FMD]) were included. Data Sources The following databases were searched: Medline, Web of Science, and Scopus. Data Extraction and Analysis Standardized mean differences in %FMD were pooled using a random-effects model and 13 studies were included in the analysis. Quality assessment was performed using the Cochrane risk-of-bias score. Results Inorganic nitrate was associated with improved Δ%FMD compared with the control; the standardized mean difference was 1.48% (95% CI: 0.70%–2.27%; P < 0.01); high heterogeneity (I2 = 98.2%) was observed. The significant effect observed remained irrespective of dose (±600 mg nitrate), duration (acute or chronic consumption), health status (± health conditions), and type of nitrate (dietary or nondietary). Notably, acute studies had a greater FMD response than chronic studies (1.93% [95% CI: 0.71%–3.15%] vs 0.90% [95% CI: 0.48%–1.31%]). More than half of the studies reviewed showed low risk of bias; the rest of the studies were classified as “some concern” due to lack of information about randomization process and lack of prespecified analysis plans. Conclusion Our results show that, from a modest number of included trials, inorganic nitrate consumption improves FMD response by more than 1%, a clinically relevant magnitude for the prevention of cardiovascular disease. Systematic Review Registration PROSPERO registration no. CRD42020191832.
No takes yet. Share an insight, caveat, or question.
Celik et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: